Registration Details for Heratis Pharma’s R&D Update Webcast on 2 November 2020
Herantis Pharma Plc (“Herantis”), an innovative drug development company aiming to revolutionize standard therapeutic approaches with leading biologic and gene therapy, today announced registration details for the upcoming webcast regarding the update on its Research & Development pipeline. Management will host a webcast on the R&D Update at 2:00 p.m. CET on Monday 2nd November 2020. To join: https://attendee.gotowebinar.com/register/1293647308971278091 After registering, you will receive a confirmation email containing information about joining the webcast. For more information,